Nanotronics Imaging
63 Flushing Avenue, Building 128, Brooklyn, NEW YORK, 11205, United States
Overview
Nanotronics develops Industrial AI solutions combining advanced optical systems, hardware, and software to clean, sort, manage, and analyze manufacturing data in real time. The company places sensors within customer plants, stores data on local servers for security, and uses AI to correlate data points into actionable insights to correct production flaws and predict future errors. Its platform aims to drive autonomous factory capabilities that increase yields, decrease waste, and support ESG goals. Nanotronics positions its technology to bring lab experimentation and R&D innovations into scalable manufacturing solutions. The company is emphasizing expanded service to healthcare and biotech manufacturers to improve production quality and reduce contamination and costs. Nanotronics builds automated microscope systems and industrial enterprise software that integrate into manufacturing supply chains for MEMS, semiconductors, aerospace hardware, nano-medicine, and DNA sequencing and storage. Its products, including nSPEC and nSPEC3D, incorporate globally patented super-resolution, 3D imaging, precision robotics, and software techniques for computer vision and artificial intelligence. The systems are designed to help manufacturers implement design and process changes rapidly, increase yields and process control, and reduce scrap and costs. The company is led by founder and CEO Dr. Matthew Putman. Customers named in the article include Broadcom, ST Micro, IQE, II-VI, Soraa and Applied Optoelectronics. Nanotronics plans to use new funding to accelerate development of its optical inspection technologies and proprietary industrial enterprise software and to expand into key regions of the Asian market in 2018. Nanotronics Imaging develops optical inspection tools that pair optical microscopy with patented image-processing and machine-intelligence algorithms to produce nanoscale-resolution imaging across very large specimen areas. Its products are used in a variety of manufacturing environments, with a focus on the semiconductor industry. The company intends to use new funding to continue to provide and scale its products and services for the semiconductor market. Nanotronics also plans to expand its offerings into new domains such as biomedical diagnostics. The firm completed a $7M Series B financing round, indicating an infusion of growth capital. CEO Matthew Putman founded the company in 2010.
- Total raised
- $37M
- Funding rounds
- 3
- Latest round
- Series D
- Latest activity
- Oct 2017
Industries
- Life Science
- Medical Device
- Nanotechnology
- Software
Recent funding
Series D
Oct 2017
$30M
Series B
Dec 2013
$7M